October 21, 2026 — Actress Christina Applegate has revealed that the multiple sclerosis (MS) diagnosis she received in 2021 was incorrect, a stunning development after five years of debilitating illness, medical treatment, and public advocacy. Her disclosure brings renewed attention to a longstanding problem in neurological medicine: patients can spend years receiving treatment for multiple sclerosis when they do not actually have the disease.
Applegate, 54, discussed the reversal of her diagnosis on the October 20 episode of her podcast, MeSsy, which she co-hosts with actress Jamie-Lynn Sigler. Although her physicians have concluded that she does not have MS, Applegate continues to experience serious neurological symptoms, including pain, mobility difficulties, and an inability to walk significant distances without assistance.
The revelation was not the moment of relief many might expect. Applegate explained that learning she did not have multiple sclerosis did nothing to resolve the suffering she continues to endure. Instead, the removal of a diagnosis that had explained her condition for years has left her facing another period of medical uncertainty.
Nearly One in Five Patients Misdiagnosed in a Major Study
The broader implications of Applegate’s experience are supported by medical research. A 2019 peer-reviewed study published in Multiple Sclerosis and Related Disorders examined patients referred with an existing MS diagnosis to two academic multiple sclerosis centers in the United States. Researchers found that approximately 18% had been incorrectly diagnosed and did not actually have multiple sclerosis.
The study, titled Incidence of Multiple Sclerosis Misdiagnosis in Referrals to Two Academic Centers, was conducted by Marwa Kaisey and colleagues at Cedars-Sinai Medical Center and the University of California, Los Angeles. The findings revealed that misdiagnosed patients could spend years receiving unnecessary disease-modifying medications, potentially exposing them to significant side effects while delaying appropriate treatment for their actual conditions.
Importantly, the 18% finding applies to patients evaluated at the two specialized referral centers included in the study. It should not be interpreted as proof that nearly one in five people diagnosed with MS worldwide have been misdiagnosed. Nevertheless, the findings demonstrate that diagnostic errors are a substantial concern within specialized neurological practice.
Why Multiple Sclerosis Is Difficult to Diagnose
Multiple sclerosis is a chronic immune-mediated disease affecting the central nervous system, including the brain, spinal cord, and optic nerves. The disease damages myelin, the protective material surrounding nerve fibers, disrupting communication between the brain and other parts of the body.
Symptoms can include muscle weakness, numbness, fatigue, visual disturbances, impaired balance, difficulty walking, and cognitive changes. However, these symptoms are not exclusive to multiple sclerosis. Other neurological, autoimmune, vascular, and metabolic conditions can produce overlapping clinical presentations.
There is no single blood test, neurological examination, or imaging result that independently establishes an MS diagnosis in every patient. Neurologists instead evaluate medical history, patterns of neurological symptoms, magnetic resonance imaging (MRI), and, when appropriate, cerebrospinal fluid findings and other laboratory tests. Diagnosis also requires careful consideration of alternative explanations.
One major source of diagnostic error involves the interpretation of MRI abnormalities. Certain white-matter changes may appear in patients with migraine, small-vessel disease, or other disorders. When nonspecific imaging findings are incorrectly attributed to multiple sclerosis, patients can receive a diagnosis that subsequent specialist evaluation does not support.
The Consequences Extend Beyond Medical Records
For a patient, an incorrect MS diagnosis can profoundly affect employment, family life, financial planning, mental health, and expectations for the future. Multiple sclerosis is generally considered a lifelong condition, and receiving that diagnosis may influence decisions about careers, mobility, relationships, and long-term care.
There are also medical consequences. Disease-modifying therapies used to manage MS alter immune-system activity and may carry risks that require careful monitoring. When a patient does not have the disease, exposure to these treatments may provide no corresponding therapeutic benefit. Meanwhile, the condition actually responsible for the symptoms may remain unidentified.
Applegate’s experience illustrates the emotional dimension of diagnostic reversal. Her public identity as a person living with MS developed over several years, during which she openly discussed physical limitations and helped raise awareness of the disease. Discovering that the original diagnosis was incorrect has not eliminated her symptoms or the practical challenges of daily life.
Medical Imaging and Diagnostic Advances
Advances in neurological imaging are creating opportunities to improve diagnostic accuracy. Researchers have investigated MRI markers that may help distinguish lesions associated with multiple sclerosis from abnormalities caused by other conditions. One example is the central vein sign, an imaging feature that can help identify patterns more characteristic of MS-related inflammation.
Such developments are important because a diagnosis must be supported by evidence that is sufficiently specific to the disease. Improved diagnostic criteria and imaging techniques can help physicians reconsider uncertain cases and reduce the likelihood of exposing patients to inappropriate treatments.
However, advanced technology does not eliminate the need for clinical judgment. A diagnosis remains an interpretation of evidence, and even sophisticated imaging must be considered alongside symptoms, examination findings, medical history, and alternative possibilities.
A Diagnosis Reversed, but the Illness Remains
Applegate’s announcement should not be mistaken for a declaration that she is healthy or that her previous symptoms were imagined. She has described continuing physical impairment and substantial limitations on her mobility. As of her October 20 disclosure, the underlying cause of those symptoms had not been publicly established.
Her case also does not mean that other patients with confirmed multiple sclerosis should question their diagnosis solely because of a celebrity’s experience or a statistical finding from referral clinics. Instead, it highlights the value of rigorous diagnostic evaluation, particularly when clinical findings are atypical, contradictory, or insufficient to support an established diagnosis.
The central lesson extends far beyond multiple sclerosis. Modern medicine has developed extraordinary diagnostic technologies, yet the distinction between identifying symptoms and correctly identifying their cause remains fundamental. Christina Applegate’s experience demonstrates how a medical label can shape years of treatment and personal decisions—and how difficult the consequences can be when that label is later removed.
Sources and Medical Research
Kaisey, M., Solomon, A. J., Luu, M., Giesser, B. S., & Sicotte, N. L. (2019). Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers. Multiple Sclerosis and Related Disorders, 30, 51–56. https://doi.org/10.1016/j.msard.2019.01.048
Associated Press. (2026, October 20). Christina Applegate says her doctor told her she was misdiagnosed with MS. Associated Press.
Agence France-Presse. (2026, October 20). Christina Applegate says she was misdiagnosed with MS. AFP.
ABC News. (2026, October 20). Why MS can be hard to diagnose, after Christina Applegate reveals misdiagnosis. ABC News.